av/brooklyn-immunotherapeutics--big.svg

NASDAQ:BTX

Eterna Therapeutics Inc.

  • Stock

USD

Last Close

0.20

17/10 04:00

Market Cap

1.05M

Beta: 0.79

Volume Today

2.56M

Avg: 85.42K

PE Ratio

−0.42

PFCF: −0.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
revenue
51K
-
17K
66.67%
47K
176.47%
47K
0%
cost of revenue
152K
-
121K
20.39%
86K
28.93%
62K
27.91%
63K
1.61%
120K
90.48%
547K
355.83%
602K
10.05%
95K
84.22%
gross profit
-152K
-
-121K
20.39%
-86K
28.93%
-62K
27.91%
-63K
1.61%
-69K
9.52%
-530K
668.12%
-555K
4.72%
-48K
91.35%
selling and marketing expenses
-481K
-
-541K
12.47%
general and administrative expenses
1.05M
-
1.03M
1.84%
1.08M
4.83%
555.35K
48.77%
1.64M
194.69%
4.62M
182.32%
4.26M
7.84%
4.35M
2.25%
4.24M
2.55%
5.43M
28.05%
3.19M
41.38%
2.77M
12.87%
3.59M
29.44%
2.51M
30.12%
3.98M
58.53%
4.51M
13.24%
4.32M
4.24%
3.90M
9.71%
selling general and administrative expenses
1.05M
-
1.03M
1.84%
1.08M
4.83%
555.35K
48.77%
1.64M
194.69%
4.62M
182.32%
4.26M
7.84%
4.35M
2.25%
4.24M
2.55%
5.43M
28.05%
3.19M
41.38%
2.77M
12.87%
3.59M
29.44%
2.51M
30.12%
3.98M
58.53%
4.03M
1.16%
3.77M
6.24%
3.90M
3.23%
research and development expenses
-38.97K
-
985.08K
2,627.73%
923.53K
6.25%
1.65M
78.81%
1.52M
7.98%
5.39M
254.87%
1.47M
72.80%
4.18M
185.07%
1.78M
57.38%
1.69M
5.44%
4.96M
194.54%
1.96M
60.47%
1.67M
14.68%
1.58M
5.68%
1.46M
7.73%
1.21M
16.95%
1.46M
20.50%
987K
32.30%
other expenses
-4.68K
-
-14.24K
204.51%
-2.56K
-
-22.19K
765.33%
-12.63K
43.09%
647K
5,224.35%
-1.14M
276.35%
-1K
99.91%
-5K
-
50K
1,100%
-280K
660%
-53K
-
cost and expenses
1.01M
-
2.02M
99.03%
2.01M
0.58%
2.21M
9.92%
3.16M
43.03%
10.01M
217.25%
5.72M
42.83%
8.54M
49.09%
6.03M
29.41%
7.12M
18.14%
8.15M
14.47%
4.74M
41.86%
5.32M
12.22%
4.09M
23.08%
5.56M
35.88%
5.78M
4.07%
5.83M
0.90%
4.98M
14.67%
operating expenses
1.01M
-
2.02M
99.03%
2.01M
0.58%
2.21M
9.92%
3.16M
43.03%
10.01M
217.25%
5.72M
42.83%
8.54M
49.09%
6.03M
29.41%
7.12M
18.14%
8.15M
14.47%
4.74M
41.86%
5.32M
12.22%
4.09M
23.08%
5.44M
32.94%
5.24M
3.70%
5.23M
0.06%
4.88M
6.67%
interest expense
12.56K
-
11.52K
8.29%
20.21K
-
18.03K
10.81%
1K
94.45%
13K
1,200%
10K
23.08%
6K
40%
105K
1,650%
114K
-
388K
240.35%
-786K
302.58%
-797K
1.40%
ebitda
-991.53K
-
-1.99M
101.16%
-1.98M
0.61%
-2.18M
10.05%
11.48M
626.33%
-9.96M
186.77%
-5.61M
43.65%
-7.96M
41.88%
-7.03M
11.76%
-6.97M
0.87%
-8.03M
15.21%
-5.04M
37.22%
-5.16M
2.36%
-3.87M
25.03%
-4.99M
28.99%
-5.28M
5.93%
-5.25M
0.72%
-4.93M
6.00%
operating income
-1.01M
-
-2.02M
99.03%
-2.01M
0.58%
-2.21M
9.92%
-8.10M
267.14%
-10.01M
23.59%
-86.33M
762.19%
-9.11M
89.45%
-6.30M
30.85%
-13.88M
120.46%
-8.30M
40.17%
-4.74M
42.96%
-5.32M
12.22%
-4.55M
14.43%
-5.50M
21.02%
-5.76M
4.72%
-5.79M
0.38%
-4.93M
14.79%
depreciation and amortization
23.00K
-
24.64K
7.13%
25.27K
2.57%
25.09K
0.71%
94.90K
278.23%
117.28K
23.59%
123.42K
5.23%
123.40K
0.02%
-732K
693.21%
6.91M
1,044.40%
277K
95.99%
-302K
209.03%
158K
152.32%
63K
60.13%
517K
720.63%
481K
6.96%
541K
12.47%
total other income expenses net
-4.68K
-
-14.24K
204.51%
-12.56K
11.84%
-11.52K
8.29%
-14.55M
126,190.54%
-72.19K
99.50%
-80.31M
111,153.10%
77K
100.10%
-3.08M
4,098.70%
10.48M
440.44%
993K
90.53%
288K
71.00%
-95K
132.99%
-439K
362.11%
20K
104.56%
-392K
2,060%
-856K
118.37%
-595K
30.49%
income before tax
-1.02M
-
-2.03M
99.51%
-2.02M
0.65%
-2.22M
9.80%
-17.70M
698.05%
-10.09M
43.03%
-86.06M
753.27%
-8.46M
90.17%
-9.38M
10.84%
-3.40M
63.75%
-7.31M
115.16%
-4.45M
39.15%
-5.41M
21.62%
-4.50M
16.76%
-5.60M
24.31%
-6.16M
9.97%
-6.64M
7.89%
-5.53M
16.81%
income tax expense
14.54M
-
-67.28K
100.46%
7.58K
111.27%
5K
34.07%
3.08M
61,480.00%
-10.48M
440.44%
5K
100.05%
40K
700%
5K
87.50%
4K
20%
-8K
300%
-4K
50%
4K
200%
-3K
175%
net income
-1.02M
-
-2.03M
99.51%
-2.02M
0.65%
-2.22M
9.80%
-17.70M
698.05%
-10.09M
43.03%
-86.06M
753.27%
-8.46M
90.17%
-12.45M
47.16%
7.08M
156.88%
-7.32M
203.27%
-4.49M
38.64%
-5.42M
20.65%
-4.51M
16.77%
-5.59M
24.02%
-6.15M
10.05%
-6.65M
8.03%
-5.54M
16.70%
weighted average shs out
2.08M
-
2.08M
0%
2.08M
0%
1.39M
33.04%
1.39M
0.00%
2.12M
52.70%
2.53M
19.06%
2.60M
2.97%
2.68M
3.04%
2.94M
9.66%
2.94M
0.03%
4.40M
49.66%
5.13M
16.48%
5.30M
3.43%
5.41M
2.02%
5.41M
0%
5.41M
0%
5.41M
0%
weighted average shs out dil
2.08M
-
2.08M
0%
2.08M
0%
1.39M
33.04%
1.39M
0.00%
2.12M
52.70%
2.53M
19.06%
2.60M
2.97%
2.68M
3.05%
2.94M
9.66%
2.94M
0.03%
4.40M
49.66%
5.13M
16.48%
5.30M
3.43%
5.41M
2.02%
5.41M
0%
5.41M
0%
5.41M
0%
eps
-0.49
-
-0.98
100%
-0.97
1.02%
-1.60
64.95%
-12.74
696.25%
-4.75
62.72%
-34.05
616.84%
-3.25
90.46%
-4.65
43.08%
2.41
151.83%
-2.49
203.32%
-1.02
59.04%
-1.06
3.92%
-0.85
19.81%
-1.03
21.18%
-1.14
10.68%
-1.23
7.89%
-1.02
17.07%
epsdiluted
-0.49
-
-0.98
100%
-0.97
1.02%
-1.60
64.95%
-12.74
696.25%
-4.75
62.72%
-34.05
616.84%
-3.25
90.46%
-4.64
42.77%
2.41
151.94%
-2.49
203.32%
-1.02
59.04%
-1.06
3.92%
-0.85
19.81%
-1.03
21.18%
-1.14
10.68%
-1.23
7.89%
-1.02
17.07%

All numbers in USD (except ratios and percentages)